Star Combo Pharma Ltd (S66) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.015x

Based on the latest financial reports, Star Combo Pharma Ltd (S66) has a cash flow conversion efficiency ratio of 0.015x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$575.23K ≈ $407.01K USD) by net assets (AU$38.68 Million ≈ $27.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Star Combo Pharma Ltd (S66) liquidity interval to measure how many days the company can operate on defensive assets alone.

Star Combo Pharma Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Star Combo Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Star Combo Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Star Combo Pharma Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kore Mining Ltd
V:KORE
0.029x
Mitra Pemuda Tbk PT
JK:MTRA
-0.004x
DevPort AB (publ)
ST:DEVP-B
-0.027x
Inventure Growth & Securities Limited
NSE:INVENTURE
0.008x
Thriven Global Bhd
KLSE:7889
0.067x
Cofidur SA
PA:ALCOF
0.273x
GreenOak Spain Holdings SOCIMI S.A.
MC:YGO2
N/A
Thunderbird Resources Ltd
AU:THB
-0.043x

Annual Cash Flow Conversion Efficiency for Star Combo Pharma Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Star Combo Pharma Ltd (S66) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$38.26 Million
≈ $27.07 Million
AU$11.94 Million
≈ $8.45 Million
0.312x +3404.96%
2024-06-30 AU$33.51 Million
≈ $23.71 Million
AU$-316.45K
≈ $-223.91K
-0.009x -116.74%
2023-06-30 AU$33.26 Million
≈ $23.53 Million
AU$1.88 Million
≈ $1.33 Million
0.056x +2193.37%
2022-06-30 AU$35.41 Million
≈ $25.05 Million
AU$87.11K
≈ $61.64K
0.002x -73.14%
2021-06-30 AU$36.19 Million
≈ $25.61 Million
AU$331.53K
≈ $234.58K
0.009x +140.03%
2020-06-30 AU$44.50 Million
≈ $31.49 Million
AU$-1.02 Million
≈ $-720.42K
-0.023x +79.06%
2019-06-30 AU$20.00 Million
≈ $14.15 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.109x +3.35%
2018-06-30 AU$16.26 Million
≈ $11.50 Million
AU$-1.84 Million
≈ $-1.30 Million
-0.113x -290.16%
2017-06-30 AU$15.68 Million
≈ $11.10 Million
AU$932.20K
≈ $659.59K
0.059x -82.19%
2016-06-30 AU$3.88 Million
≈ $2.75 Million
AU$1.30 Million
≈ $917.50K
0.334x --

About Star Combo Pharma Ltd

AU:S66 Australia Household & Personal Products
Market Cap
$10.99 Million
AU$15.53 Million AUD
Market Cap Rank
#26807 Global
#1279 in Australia
Share Price
AU$0.12
Change (1 day)
+0.00%
52-Week Range
AU$0.11 - AU$0.27
All Time High
AU$1.72
About

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more